Images

Flu Vaccine (Student)

  • WHO recommends vaccine's product

    WHO recommends vaccine's product
    Following tests on the various H1N1 strains found across the world, WHO recommends that vaccines for the pandemic H1N1 virus contain it's closest relative, the virus A/California/7/2009(H1N1)v
  • GSK recieves starin H1N1 virus

    GSK recieves starin H1N1 virus
    GlaxoSmithKline (GSK) begins developing the H1N1 vaccine.
  • GlaxoSmithKline's vaccine

    GlaxoSmithKline's vaccine
    The government of Canada has a contract since 2001 with GSK to maintain vaccine production capacity in Canada.
  • WHO declares H1N1 pandemic

    WHO declares H1N1 pandemic
    WHO declares a phase six pandemic of the H1N1 swine flu, the highest on the scale.
    A phase six pandemic means that there is a human-to-human spread of the virus and that there is a community outbreak in more than one country in different parts of the world.
  • Canada orders vaccines from GSK

    Canada orders vaccines from GSK
    Health Minister Leona Aglukkaq announce that the government of Canada will place an order for 50.4 million doses of H1N1 vaccine.
    A $400 million contract
  • H1N1 human tests begin

    H1N1 human tests begin
    GSK, the manufacturer of Canada's swine flu vaccine, starts testing the vaccine on people. GSK says it plans to test its vaccine on more than 9,000 people in Canada, the United States and Europe as part of 16 clinical trials.
    The first trial — based in Germany — will assess the use of the vaccine given as two doses, 21 days apart in 128 healthy adults, aged between 18 and 60.
  • GSK release German trial results

    GSK release German trial results
    According to the results, more than 98 per cent of subjects who receive a first dose of 5.25 micrograms of vaccine show signs of protection three weeks later
  • H1N1 vaccine approved for rollout

    H1N1 vaccine approved for rollout
    Health Canada authorizes the rollout of the H1N1 vaccine.
    One dose of the H1N1 vaccine seems to offer immunity in the "high 90s" in healthy adults, said Butler-Jones, Canada's chief public health officer.
  • H1N1 vaccine safe after millions of doses: WHO

    H1N1 vaccine safe after millions of doses: WHO
    WHO says that the vaccine is safe after millions of doses have been given so far and no unusual side-effects have been seen. (Darren Calabrese/Canadian Press)
  • H1N1 pandemic officially over: WHO

    H1N1 pandemic officially over: WHO
    The World Health Organization has declared that the H1N1 pandemic, which killed more than 18,000 people around the world and sparked mass vaccination programs, is over. WHO director general Margaret Chan said Tuesday that the pandemic has "largely run its course."